Latest MBX Analyst Ratings & Recommendations
Recent analyst recommendations with rating changes and price target updates (last 90 days)
| Date | Analyst | Firm | Action | Rating | Price Target |
|---|---|---|---|---|---|
| Seamus Fernandez | Guggenheim | Reiterates | Buy | $88.00 | |
| Patrick Dolezal | LifeSci Capital | Maintains | Buy | $91.00 | |
| Seamus Fernandez | Guggenheim | Reiterates | Buy | $88.00 | |
| Srikripa Devarakonda | Truist | Reiterates | Buy | $70.00 | |
| Eliana Merle | Barclays | Maintains | Buy | $70.00 | |
| Unknown Analyst | Oppenheimer | Reiterates | Buy | $80.00 | |
| PerPlexity Biotechnology | TipRanks - PerPlexity | Reiterates | Hold | $31.00 → $38.00 +7.00 (22.6%) | |
| OpenAI Biotechnology | TipRanks - OpenAI | Reiterates | Hold | $31.00 → $37.00 +6.00 (19.4%) | |
| Uy Ear | Mizuho | Reiterates | Buy | $37.25 → $57.00 +19.75 (53.0%) | |
| Uy Ear | Mizuho | Reiterates | Buy | $57.00 | |
| Patrick Dolezal | LifeSci Capital | Maintains | Buy | $75.00 → $91.00 +16.00 (21.3%) | |
| Annabel Samimy | Stifel Nicolaus | Reiterates | Buy | $50.00 → $56.00 +6.00 (12.0%) | |
| Jonathan Wolleben | Citizens JMP | Maintains | Buy | $76.00 → $86.00 +10.00 (13.2%) | |
| Eliana Merle | Barclays | Reiterates | Buy | $66.00 → $70.00 +4.00 (6.1%) | |
| Unknown Analyst | Oppenheimer | Reiterates | Buy | $80.00 | |
| Srikripa Devarakonda | Truist | Maintains | Buy | $50.00 → $70.00 +20.00 (40.0%) | |
| Seamus Fernandez | Guggenheim | Reiterates | Buy | $88.00 | |
| Tyler Van Buren | TD Cowen | Maintains | Buy | - |
